Cancer Research UK logo.
SearchDonate
  • Search

A study looking at the effects of a drug called Reolysin in people with cancer affecting the brain (REO 13 BRAIN)

Overview

Cancer types:

Brain (and spinal cord) tumours, Cancer spread to the brain, Secondary cancers

Status:

Closed

Phase:

Phase 1

Details

This study is looking at a drug called Reolysin in people with cancer that started in, or has spread to, the brain.

Recruitment start: 28 June 2013

Recruitment end: 10 December 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Alan Melcher

Professor Susan Short

Supported by

Brain Tumour Research and Support across Yorkshire (BTRS)

Experimental Cancer Medicine Centre (ECMC)

Oncolytics Biotech Inc.

University of Leeds

Last reviewed: 28 September 2016

CRUK internal database number: 9900

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.